Ivermectin suspending agent, preparation method and application thereof
A technology of ivermectin and suspoemulsion, which is applied in the directions of medical preparations containing active ingredients, pharmaceutical formulations, and emulsion delivery, etc., can solve the problems of ivermectin suspoemulsion with significant sustained-release effect, and achieve sustained-release effect. Significant, filling technology gap, low manufacturing cost effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0042] Embodiment 1: 3% ivermectin suspoemulsion
[0043] Prepare each component according to the following ratios, and all components are conventional medicinal materials (commercially available):
[0044] Ivermectin API 30g;
[0045] Camellia oil 500g;
[0046] Tween 80 50g;
[0047] Add water for injection to 1000mL.
[0048] The preparation method is:
[0049] (1) Weigh the ivermectin bulk drug and camellia oil according to the proportion, and mix them uniformly through a colloid mill to obtain an oil phase; there is no special requirement for the colloid mill, as long as the effect of uniform mixing can be achieved.
[0050] (2) Weigh Tween 80, add a small amount of water for injection and stir to dissolve Tween 80 to obtain an aqueous phase;
[0051] (3) adding the water phase to the oil phase, and mixing uniformly through a colloid mill;
[0052] (4) Add water to the full amount, stir well to obtain the suspoemulsion of ivermectin.
Embodiment 2
[0053] Embodiment 2: 2% ivermectin suspoemulsion
[0054] Prepare each component according to the following proportions, and all components are conventional medicinal materials:
[0055] Ivermectin API 20g;
[0056] 300g peanut oil;
[0057] 200g corn oil;
[0058] Poloxamer 70g;
[0059] Soy lecithin 30g;
[0060] Add water for injection to 1000mL.
[0061] The preparation method is:
[0062] (1) Weigh the ivermectin bulk drug, peanut oil, and corn oil in proportion, and mix them uniformly through a colloid mill to obtain an oil phase;
[0063] (2) Weighing the poloxamer and soybean lecithin, adding a small amount of water for injection, stirring and dissolving, to obtain an aqueous phase;
[0064] (3) adding the water phase to the oil phase, and mixing uniformly through a colloid mill;
[0065] (4) Add water to the full amount, stir well to obtain the suspoemulsion of ivermectin.
Embodiment 3
[0066] Embodiment 3: 0.2% ivermectin suspoemulsion
[0067] Prepare each component according to the following proportions, and all components are conventional medicinal materials:
[0068] Ivermectin 2g;
[0069] 550g peanut oil;
[0070] Poloxamer 70g;
[0071] Methylcellulose 3.5g;
[0072] Add water for injection to 1000mL.
[0073] The preparation method is:
[0074] (1) Weigh the ivermectin bulk drug and peanut oil in proportion, and mix them uniformly through a colloid mill to obtain an oil phase;
[0075] (2) Weighing poloxamer and methylcellulose, adding a small amount of water for injection and stirring to dissolve to obtain an aqueous phase;
[0076] (3) adding the water phase to the oil phase, and mixing uniformly through a colloid mill;
[0077] (4) Add water to the full amount, stir well to obtain the suspoemulsion of ivermectin.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com